Comments
Loading...

Verona Pharma

VRNANASDAQ
Logo brought to you by Benzinga Data
$29.23
0.040.14%
At Close: -
$29.23
00.00%
After Hours: 4:53 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$38.00
Lowest Price Target1
$31.00
Consensus Price Target1
$35.17

Verona Pharma (NASDAQ:VRNA) Stock, Analyst Ratings, Price Targets, Forecasts

Verona Pharma PLC has a consensus price target of $35.17 based on the ratings of 6 analysts. The high is $38 issued by Truist Securities on June 28, 2024. The low is $31 issued by BTIG on March 20, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Canaccord Genuity on September 17, 2024, September 11, 2024, and July 22, 2024, respectively. With an average price target of $36.33 between HC Wainwright & Co., HC Wainwright & Co., and Canaccord Genuity, there's an implied 24.30% upside for Verona Pharma PLC from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Jul
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Canaccord Genuity
Truist Securities
Piper Sandler
Wedbush

1calculated from analyst ratings

Analyst Ratings for Verona Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Verona Pharma (VRNA) stock?

A

The latest price target for Verona Pharma (NASDAQ:VRNA) was reported by HC Wainwright & Co. on September 17, 2024. The analyst firm set a price target for $36.00 expecting VRNA to rise to within 12 months (a possible 23.16% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Verona Pharma (VRNA)?

A

The latest analyst rating for Verona Pharma (NASDAQ:VRNA) was provided by HC Wainwright & Co., and Verona Pharma reiterated their buy rating.

Q

When was the last upgrade for Verona Pharma (VRNA)?

A

There is no last upgrade for Verona Pharma

Q

When was the last downgrade for Verona Pharma (VRNA)?

A

There is no last downgrade for Verona Pharma.

Q

When is the next analyst rating going to be posted or updated for Verona Pharma (VRNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verona Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verona Pharma was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

Q

Is the Analyst Rating Verona Pharma (VRNA) correct?

A

While ratings are subjective and will change, the latest Verona Pharma (VRNA) rating was a reiterated with a price target of $36.00 to $36.00. The current price Verona Pharma (VRNA) is trading at is $29.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch